Open Access
Volume 3, 2017
Article Number 27
Number of page(s) 6
Section Knee
Published online 22 March 2017
  1. Boswell SG, Cole BJ, Sundman EA, et al. (2012) Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy 28(3), 429–439. [CrossRef] [PubMed] [Google Scholar]
  2. Akeda K, An HS, Okuma M, et al. (2006) Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartil 14(12), 1272–1280. [CrossRef] [Google Scholar]
  3. Pereira RC, Scaranari M, Benelli R, et al. (2013) Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution. Tissue Eng Part A 19(11–12), 1476–1488. [CrossRef] [PubMed] [Google Scholar]
  4. Park SI, Lee HR, Kim S, et al. (2012) Time sequential modulation in expression of growth factors from platelet-rich plasma (PRP) on the chondrocyte cultures. Mol Cell Biochem 361(1–2), 9–17. [CrossRef] [PubMed] [Google Scholar]
  5. Yang SY, Ahn ST, Rhie JW, et al. (2000) Platelet supernatant promotes proliferation of auricular chondrocytes and formation of chondrocyte mass. Ann Plast Surg 44(4), 405–411. [CrossRef] [PubMed] [Google Scholar]
  6. Spreafico A, Chellini F, Frediani B, et al. (2009) Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem 108(5), 1153–1165. [CrossRef] [PubMed] [Google Scholar]
  7. Gaissmaier C, Fritz J, Krackhardt T, et al. (2005) Effect of human platelet supernatant on proliferation and matrix synthesis of human articular chondrocytes in monolayer and three-dimensional alginate cultures. Biomaterials 26(14), 1953–1960. [CrossRef] [PubMed] [Google Scholar]
  8. Sundman EA, Cole BJ, Karas V, et al. (2014) The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med 42(1), 35–41. [CrossRef] [Google Scholar]
  9. Anitua E, Sanchez M, Nurden AT, et al. (2007) Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patientsm. Rheumatology (Oxford) 46(12), 1769–1772. [CrossRef] [PubMed] [Google Scholar]
  10. Yin Z, Yang X, Jiang Y, et al. (2013) Platelet-rich plasma combined with agarose as a bioactive scaffold to enhance cartilage repair: an in vitro study. J Biomater Appl 28(7), 1039–1050. [CrossRef] [PubMed] [Google Scholar]
  11. Mifune Y, Matsumoto T, Takayama K, et al. (2013) The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair. Osteoarthritis Cartil 21(1), 175–185. [CrossRef] [Google Scholar]
  12. van Buul GM, Koevoet WL, Kops N, et al. (2011) Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports Med 39(11), 2362–2370. [CrossRef] [Google Scholar]
  13. Bendinelli P, Matteucci E, Dogliotti G, et al. (2010) Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-jB inhibition via HGF. J Cell Physiol 225(3), 757–766. [CrossRef] [PubMed] [Google Scholar]
  14. Wu CC, Chen WH, Zao B, et al. (2011) Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials 32(25), 5847–5854. [CrossRef] [PubMed] [Google Scholar]
  15. Lee HR, Park KM, Joung YK, et al. (2012) Platelet rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2. J Control Release 159(3), 332–337. [CrossRef] [PubMed] [Google Scholar]
  16. Anitua E, Sanchez M, Orive G, et al. (2007) The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 28, 4551–4560. [CrossRef] [PubMed] [Google Scholar]
  17. Patel S, Dhillon MS, Aggarwal S, et al. (2013) Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 41, 356–364. [CrossRef] [PubMed] [Google Scholar]
  18. Kon E, Buda R, Filardo G, et al. (2010) Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 18, 472–479. [CrossRef] [PubMed] [Google Scholar]
  19. Mishra A, Harmon K, Woodall J, et al. (2012) Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol 13, 1185–1195. [CrossRef] [PubMed] [Google Scholar]
  20. DeLong JM, Russell RP, Mazzocca AD (2012) Platelet-rich plasma: the PAW classification system. J Arthrosc Relat Surg 28, 998–1009. [Google Scholar]
  21. Arnoczky SP, Delos D, Rodeo SA (2011) What is platelet-rich plasma? Oper Tech Sports Med 19(3), 142–148. [CrossRef] [Google Scholar]
  22. Busilacchi A, Gigante A, Mattioli-Belmonte M, et al. (2013) Chitosan stabilizes platelet growth factors and modulates stem cell differentiation toward tissue regeneration. Carbohydr Polym 98(1), 665–676. [CrossRef] [Google Scholar]
  23. Kutlu B, Aydın RST, Akman AC, et al. (2013) Platelet-rich plasma-loaded chitosan scaffolds: preparation and growth factor release kinetics. J Biomed Materials Res Part B: Applied Biomaterials 101(1), 28–35. [CrossRef] [Google Scholar]
  24. Saito M, Takahashi KA, Arai Y, et al. (2009) Intra-articular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee. Clin Exp Rheumatol 27(2), 201–207. [PubMed] [Google Scholar]
  25. Dhillon M, Patel S, Bali K (2011) Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 19, 863–864, author reply 865-866. [CrossRef] [PubMed] [Google Scholar]
  26. Pifer MA, Maerz T, Baker KC, et al. (2014) Matrix metalloproteinase content and activity in low-platelet, low-leukocyte and high-platelet, high-leukocyte platelet rich plasma (PRP) and the biologic response to PRP by human ligament fibroblasts. Am J Sports Med 42(5), 1211–1218. [CrossRef] [Google Scholar]
  27. Braun HJ, Kim HJ, Chu CR, et al. (2014) The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy. Am J Sports Med 42(5), 1204–1210. [CrossRef] [Google Scholar]
  28. Dragoo JL, Braun HJ, Durham JL, et al. (2012) Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med 40(6), 1274–1281. [CrossRef] [Google Scholar]
  29. Filardo G, Kon E, Pereira Ruiz MT, et al. (2012) Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double- spinning approach. Knee Surg Sports Traumatol Arthrosc 20(10), 2082–2091. [CrossRef] [PubMed] [Google Scholar]
  30. Cavallo C, Filardo G, Mariani E, et al. (2014) Comparison of platelet rich plasma formulations for cartilage healing: an in vitro study. J Bone Joint Surg (Am) 96(5), 5423–5429. [CrossRef] [Google Scholar]
  31. Riboh JC, Saltzman BM, Yanke AB, et al. (2016) Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med 44(3), 792–800. [CrossRef] [Google Scholar]
  32. Magalon J, Bausset O, Serratrice N, et al. (2014) Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthroscopy 30(5), 629–638. [CrossRef] [PubMed] [Google Scholar]
  33. Mazzocca AD, McCarthy MBR, Chowaniec DM, et al. (2012) Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg (Am) 94(4), 308–316. [CrossRef] [Google Scholar]
  34. Blajchman MA (2001) Novel platelet products, substitutes and alternatives. Transfus Clin Biol 8, 267–271. [CrossRef] [PubMed] [Google Scholar]
  35. Roffi A, Filardo G, Assirelli E, et al. (2014) Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes? Biomed Res Int 2014, 692913. [CrossRef] [PubMed] [Google Scholar]
  36. Sanchez M, Anitua E, Azofra J, et al. (2008) Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol 26, 910–913. [PubMed] [Google Scholar]
  37. Spakova T, Rosocha J, Lacko M, et al. (2012) Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil 91, 411–417. [CrossRef] [PubMed] [Google Scholar]
  38. Cerza F, Carnì S, Carcangiu A, et al. (2012) Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med 40, 2822–2827. [CrossRef] [PubMed] [Google Scholar]
  39. Kon E, Mandelbaum B, Buda R, et al. (2011) Platelet-rich plasma intraarticular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 27, 1490–1501. [CrossRef] [PubMed] [Google Scholar]
  40. Filardo G, Kon E, Buda R, et al. (2011) Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 19, 528–535. [CrossRef] [PubMed] [Google Scholar]
  41. Filardo G, Di Matteo B, Martino Di, et al. (2015) Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial. Am J Sports Med 43(7), 1575–1582. [CrossRef] [Google Scholar]
  42. Sanchez M, Fiz N, Azofra J, et al. (2012) A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy 28(8), 1070–1078. [CrossRef] [PubMed] [Google Scholar]
  43. Li M, Zhang C, Ai Z, et al. (2011) Therapeutic effectiveness of intra-knee-articular injection of platelet-rich plasma on knee articular cartilage degeneration. Zhongguo Xiu Fu Chong JianWai Ke Za Zhi 25(10), 1192–1196. [Google Scholar]
  44. Say F, Gürler D, Yener K, et al. (2013) Platelet-rich plasma injection is more effective than hyaluronic acid in the treatment of knee osteoarthritis. Acta Chir Ortho Traumatol Cech 80(4), 278–283. [Google Scholar]
  45. Patel S, Dhillon MS (2014) The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis: letter to the editor. Am J Sports Med 30, 42. [Google Scholar]
  46. Görmeli G, Görmeli CA, Ataoglu B, et al. (2015) Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc, DOI: 10.1007/s00167-015-3705-6. [Google Scholar]
  47. Gobbi A, Lad D, Karnatzikos G (2015) The effects of repeated intra-articular PRP injections on clinical outcomes of early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc 23(8), 2170–2177. [CrossRef] [PubMed] [Google Scholar]
  48. Hart R, Safi A, Komázk M, et al. (2013) Platelet-rich plasma in patients with tibiofemoral cartilage degeneration. Arch Orthop Trauma Surg 133(9), 1295–1301. [CrossRef] [Google Scholar]
  49. Hassan AS, El-Shafey AM, Ahmed HS, et al. (2015) Effectiveness of the intra-articular injection of platelet rich plasma in the treatment of patients with primary knee osteoarthritis. Egypt Rheumatol 37(3), 119–124. [CrossRef] [Google Scholar]
  50. Sánchez M, Fiz N, Guadilla J, et al. (2014) Intraosseous infiltration of platelet-rich plasma for severe knee osteoarthritis. Arthrosc Tech 3(6), e713–e717. [CrossRef] [PubMed] [Google Scholar]
  51. Paterson KL, Nicholls M, Bennell KL, et al. (2016) Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: a double-blind, randomized controlled pilot study. BMC Musculoskelet Disord 17, 67. [CrossRef] [PubMed] [Google Scholar]
  52. Sanchez M, Guadilla J, Fiz N, et al. (2012) Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology 51, 144–150. [CrossRef] [PubMed] [Google Scholar]
  53. Battaglia M, Guaraldi F, Vannini F, et al. (2013) Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics 36(12), e1501–e1508. [CrossRef] [PubMed] [Google Scholar]
  54. Dallari D, Stagni C, Rani N, et al. (2016) Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: a randomized controlled study. Am J Sports Med 44(3), 664–671. [CrossRef] [Google Scholar]
  55. Mei-Dan O, Carmont MR, Laver L, et al. (2012) Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med 40(3), 534–541. [CrossRef] [PubMed] [Google Scholar]
  56. Anitua E, Sanchez M, De la Fuente M, et al. (2012) Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid. Knee Surg Sports Traumatol Arthrosc 20, 1657–1665. [CrossRef] [PubMed] [Google Scholar]
  57. Marmotti A, Bruzzone M, Bonasia DE, et al. (2012) One-step osteochondral repair with cartilage fragments in a composite scaffold. Knee Surg Sports Traumatol Arthrosc 20, 2590–2601. [CrossRef] [PubMed] [Google Scholar]
  58. Andia I, Abate M(2014) Knee osteoarthritis: hyaluronic acid, platelet-rich plasma or both in association? Expert Opin Biol Ther 14, 635–649. [CrossRef] [Google Scholar]
  59. Lana JF, Weglein A, Sampson S, et al. (2016) Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee. J Stem Cells Regen Med 12(2), 69–78. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.